OctreotideThird Party Manufacturing in India

Octreotide works by mimicking the natural hormone somatostatin but with a significantly longer half-life.

It binds to somatostatin receptors to inhibit the secretion of various hormones, including growth hormone, glucagon, insulin, serotonin, and gastrin. This broad inhibitory effect helps the body control severe diarrhea and flushing episodes associated with certain types of tumors, and reduces splanchnic blood flow.

Unlike natural somatostatin, Octreotide has a prolonged duration of action, making it clinically practical. It is highly effective for managing acromegaly and symptoms of neuroendocrine tumors.

Therapeutic Uses

Octreotide is prescribed for the treatment of:

• Acromegaly: To reduce blood levels of growth hormone and IGF-1 in patients who have had inadequate response to conventional treatments.
• Carcinoid Tumors: For the symptomatic treatment of patients with metastatic carcinoid tumors where it suppresses severe diarrhea and flushing episodes.
• VIPomas: For the treatment of the profuse watery diarrhea associated with VIP-secreting tumors.

Why Manufacturers Choose Octreotide

Octreotide is a specialized peptide hormone with high clinical value in endocrinology and gastroenterology. The manufacturing of peptide injectables requires advanced sterile facilities, positioning manufacturers with these capabilities as premium partners.

This makes Octreotide one of the most sought-after molecules for third party manufacturing in India, with strong demand from specialized pharmaceutical companies and international markets.